Literature DB >> 22365285

Median levels of serum biomarkers of fetal Down syndrome detected during the first trimester among pregnant Thai women.

Suchaya Luewan1, Supatra Sirichotiyakul, Yuri Yanase, Kuntharee Traisrisilp, Theera Tongsong.   

Abstract

OBJECTIVE: To develop Thai-specific medians of serum pregnancy-associated plasma protein A (PAPP-A) and free β-human chorionic gonadotropin (hCG) levels during the first trimester of pregnancy and to compare these values to a Caucasian-specific model for the detection of fetal Down syndrome.
METHODS: Serum concentrations of PAPP-A and free β-hCG were measured during the first trimester in a group of 2339 Thai women undergoing normal singleton pregnancies.
RESULTS: Thai reference ranges of PAPP-A and free β-hCG were established by gestational age (70-98 days). The equation of best fit for PAPP-A was: predicted median PAPP-A level=28.767 - 0.781×(gestational age in days)+0.006×(gestational age in days)(2); r=0.986. The equation of best fit for free β-hCG was: predicted median free β-hCG level=465.332×10((-0.024×gestational age in days)); r=0.881. Weight-corrected models were also derived for each biomarker. The Thai-specific reference ranges gave higher positive screening rates than the Caucasian-specific model, even after weight correction (5.1% versus 4.0%). The Thai-specific models were validated in an independent group of 302 pregnant women.
CONCLUSION: Ethnic group-specific medians for PAPP-A and free β-hCG should be incorporated during first-trimester screening for fetal Down syndrome.
Copyright © 2012 International Federation of Gynecology and Obstetrics. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365285     DOI: 10.1016/j.ijgo.2011.11.026

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  4 in total

1.  Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia.

Authors:  Suchaya Luewan; Monrudee Teja-Intr; Supatra Sirichotiyakul; Theera Tongsong
Journal:  Singapore Med J       Date:  2017-04-28       Impact factor: 1.858

2.  Normative weight-adjusted models for the median levels of first trimester serum biomarkers for trisomy 21 screening in a specific ethnicity.

Authors:  Ounjai Kor-Anantakul; Thitima Suntharasaj; Chitkasaem Suwanrath; Tharangrut Hanprasertpong; Savitree Pranpanus; Ninlapa Pruksanusak; Suthiraporn Janwadee; Alan Geater
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

3.  Evaluating the Agreement of Risk Categorization for Fetal Down Syndrome Screening between Ultrasound-Based Gestational Age and Menstrual-Based Gestational Age by Maternal Serum Markers.

Authors:  Pakorn Chaksuwat; Supatra Sirichotiyakul; Suchaya Luewan; Theera Tongsong
Journal:  Obstet Gynecol Int       Date:  2018-03-08

4.  Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening.

Authors:  Chanane Wanapirak; Wirawit Piyamongkol; Supatra Sirichotiyakul; Fuanglada Tongprasert; Kasemsri Srisupundit; Suchaya Luewan; Kuntharee Traisrisilp; Phudit Jatavan; Theera Tongsong
Journal:  BMC Health Serv Res       Date:  2019-11-27       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.